Zoekresultaten - 19 results
Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework.
Cocuzza, Clementina E; Steven Van Gucht; Marc Van Ranst; M. Arbyn Source: Microbiol Spectr (2024) Keywords: Allplex COVID-19 diagnostics test accuracy Quality Control reference materials RT-PCR SARS-CoV-2 ...
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
factors for HPV infection that collected samples from anogenital sites and used PCR or hybrid capture 2 techniques for HPV DNA detection. Exclusion criteria were studies conducted among populations at ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
cervical cancer screening should be clinically validated according to international criteria. OncoPredict HPV ® Screening (SCR) is a partial genotyping multiplex real-time PCR assay targeting E6 / E7 genes ...
Diagnostic accuracy of p16(INK4a) immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
mRNA detection using an amplification-based method (gold standard to indicate a transforming relevance of HPV) in OPSCC. Testing with one or more comparator tests (HPV DNA PCR, HPV DNA in situ ...
Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections.
understand (p <0.001) and to use (p=0.002). DISCUSSION: This study confirms that hr- HPV testing with a clinically validated PCR-based HPV assay is as accurate on self-samples as on clinician-samples ...
Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.
prevalence was stratified by age and cytology grade and compared with the luminex typing assay incorporating a GP5 +6+ PCR (GP5 +/6+ LMNX Assay). Clinical outcomes were compared with GP5 +/6+ EIA. RESULTS: ...
Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).
papillomavirus (hrHPV) PCR-based assay to detect high-grade cervical intraepithelial neoplasia (CIN2 +) in self-collected vaginal and urine samples. SETTING: Women attending routine cervical screening in ...
VALGENT: A protocol for clinical validation of human papillomavirus assays.
laboratories in Antwerp (Belgium) and Edinburgh (Scotland), were completed. Two new assays (G5 +/6+ PCR- LMNX and Xpert HPV) were validated for screening by showing similar accuracy for cervical precancer as the ...
Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework.
+/6+ PCR enzyme immunoassay (EIA) and the GP5 +/6+ PCR LMNX assay (Diassay) were tested with the Onclarity assay. Type-specific HPV prevalences were analyzed according to age and cytological result. The ...
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
expert team in 2009, based on reproducibility and relative sensitivity and specificity compared to Hybrid Capture-2 or GP5 +/6+ PCR-enzyme immunoassay. These latter two hrHPV DNA assays were validated in ...